Home / Companies / Apellis Pharmaceuticals, Inc. / 5 Jun 2024
Apellis Pharmaceuticals, Inc.: meeting of 5 Jun 2024
Votes reported on Form N-PX, item by item
479 Form N-PX filers reported votes at the Apellis Pharmaceuticals, Inc. meeting of 5 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 73.8% of reported votes for; 106 filers withheld from or voted against at least one nominee.
635 vote records from 182 filers. 2 of the 182 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
674 vote records from 474 filers. 93 of the 460 filers that marked the item either way voted against management. 14 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
317 vote records from 181 filers. 2 of the 181 filers that marked the item either way voted against management.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | Split or no vote | For | For |
| Franklin Templeton | For | Against * | For |
| Invesco | Split or no vote | For | For |
| Equitable | For | For | For |
| Charles Schwab | Split or no vote | For | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | For | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | Against * | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| First Trust | Split or no vote | For | For |
| Russell Investments | For | Against * | For |
| Nationwide | Split or no vote | For | For |
| Victory Capital | For | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | Split or no vote | For | For |
| Principal | Split or no vote | For | For |
| Pacific Life funds | For | For | For |
| AllianceBernstein | No report | For | No report |
| Hartford Funds | For | For | For |
| DWS | Split or no vote | For | For |
| Allspring | Split or no vote | For | For |
| MassMutual | For | For | For |
| Macquarie and Delaware Funds | Split or no vote | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Lord Abbett | Split or no vote | For | For |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Apellis Pharmaceuticals, Inc. meeting?
479 Form N-PX filers reported votes at the meeting of 5 Jun 2024. On say-on-pay, 93 of 460 voted against management (20.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Apellis Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Apellis Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Apellis Pharmaceuticals, Inc. with a meeting date within three days of 5 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.